Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

DeVry's (DV) Healthcare Units Impress, Universities A Drag

Published 09/15/2016, 08:53 AM
Updated 07/09/2023, 06:31 AM

On Sep 14, 2016, we issued an updated research report on DeVry Education Group Inc. (NYSE:DV) , a provider of educational services worldwide.

Headquartered in Downers Grove, IL, DeVry provides secondary and post-secondary education, primarily in the U.S., as well as in Canada, some Caribbean countries, Brazil, Europe, the Middle East and the Pacific Rim.

Recently, DeVry reported robust fourth-quarter fiscal 2016 results, surpassing the Zacks Consensus Estimate for both sales and earnings for the second quarter in a row. The company’s earnings increased year over year owing to improved operating performance. Although DeVry’s revenues declined 0.3%, the rate of decline was narrower than the company’s expectation of a 2–3% decline.

Among its three reporting segments, two units -- health care and international institutions -- have shown significant improvement in revenues and profitability throughout fiscal 2013, fiscal 2014 and fiscal 2015. The trend continued in fiscal 2016 as well.

Particularly, healthcare institutions, Chamberlain and Ross, gained on strong demand for jobs in the field of healthcare across the U.S. There is an acute shortage of trained nurses worldwide. There are even fewer numbers of infrastructure and faculties to train nurses. As a result, demand for these nursing programs is huge. The company believes that this demand supply gap will continue driving growth at the segment in the near term. Medical and Healthcare segment represented 50.8% of revenues in fiscal 2016 – an improvement of about 9% year over year.

That said, the company has been witnessing a persistent decline in enrollments at its flagship institution, DeVry University, which accounts for a major portion of its revenues. DeVry’s net sales declined 3.5% year over year in fiscal 2016 due to weak enrollment trends at DeVry University. Higher growth investments in health care schools and declining enrollment levels at DeVry University due to soft demand have been hurting the company’s profits over the past few quarters. DeVry does not expect its results to show any significant improvement in the near term.

Apart from DeVry, another private education company Capella Education Company (NASDAQ:CPLA) is struggling to attain decent enrollment levels.

Nevertheless, the company is undertaking several student-focused initiatives at DeVry University to return to growth and transform this business. The transformation moves for the university includes the improvement of both student experience and affordability of the programs, and strategically marketing DeVry University. These strategies are designed to make DeVry University more appealing to students and improve persistence rate. However, all these initiatives are yet to pay off and will take time to show results.

Zacks Rank & Key Picks

DeVry carries a Zacks Rank #3 (Hold). Better-ranked stocks in the consumer discretionary sector include Lincoln Educational Services Corporation (NASDAQ:LINC) , Apollo Education Group Inc. and New Oriental Education & Technology Group Inc. (NYSE:EDU) . While Lincoln Educational Services sports a Zacks Rank #1 (Strong Buy), Apollo Education Group and New Oriental Education & Technology Group hold a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

DEVRY EDUCATION (DV): Free Stock Analysis Report

CAPELLA EDUCATN (CPLA): Free Stock Analysis Report

NEW ORIENTAL ED (EDU): Free Stock Analysis Report

LINCOLN EDUCATL (LINC): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.